Mark Mann

Vaccine dispute should be a lesson for Canada-China commercialization exchanges

Mark Mann
August 19, 2020

The vaccine candidate Ad5-nCoV that's currently being held up from entering Canada by Chinese customs was developed using technology licensed from Canada's National Research Council. The warning signs were all there.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics
Organizations: AstraZeneca, CanSino Biologics, Five Eyes, National Research Council (NRC), University of Ottawa, and University of Oxford
People: Dr. Amir Attaran and Dr. Kulvinder Gill
Topics: China, COVID-19 vaccine candidates, international research collaboration, and international research partnerships

Other News

Open Science offers economic benefits, but not without structural changes and researcher buy-in

The Short Report - August 19, 2020: Blocked vaccine was made with Canadian tech, Competition Bureau takes on Amazon, and more

Canada’s research ecosystem makes recommendations ahead of the upcoming federal budget, part 1

Canada’s AI skills gap includes business leaders, data scientists and educators: report






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.